Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prekallikrein activator

M J Gallimore, P Friberger

    Thrombosis and Haemostasis
    |December 29, 1984
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    More on: Pathogenic antibodies to coagulation factors. Part II: Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, protein C and von Willebrand factor.

    Journal of thrombosis and haemostasis : JTH·2006
    Same author

    More on: Discovery of alpha2-plasmin inhibitor and its congenital deficiency.

    Journal of thrombosis and haemostasis : JTH·2006
    Same author

    Urokinase induced fibrinolysis in thromboelastography: a model for studying fibrinolysis and coagulation in whole blood.

    Journal of thrombosis and haemostasis : JTH·2005
    Same author

    The antigenic binding site(s) of antibodies to factor XII associated with the antiphospholipid syndrome.

    Journal of thrombosis and haemostasis : JTH·2005
    Same author

    Changes in high molecular weight kininogen levels during and after cardiopulmonary bypass surgery measured using a chromogenic peptide substrate assay.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2002
    Same author

    Antibodies to factor XII are distinct from antibodies to prothrombin in patients with the anti-phospholipid syndrome.

    Thrombosis and haemostasis·2002
    Same journal

    Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders.

    Thrombosis and haemostasis·2026
    Same journal

    The Interaction of Fibrin with Endothelial Cell Receptor N-Cadherin Promotes Fibrin-Dependent Angiogenesis.

    Thrombosis and haemostasis·2026
    Same journal

    Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

    Thrombosis and haemostasis·2026
    Same journal

    Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?

    Thrombosis and haemostasis·2026
    Same journal

    Methylglyoxal Promotes RBC-Driven Procoagulant Activity and Venous Thrombosis under Diabetes-Relevant Conditions.

    Thrombosis and haemostasis·2026
    Same journal

    Management of Inferior Vena Cava Thrombosis: Guidance from the Italian Society for the Study of Haemostasis and Thrombosis.

    Thrombosis and haemostasis·2026
    See all related articles